Hello you very wonderful and intelligent people that make up this forum. I sincerely hope you are doing well and things are going positive for you.
I have always been interested in stocks that have drugs ready to be approved for the market and are going through a Prescription Drug User Fee Act, which is before a drug is released on the market.
I please kindly wondered if it would be reasonable to invest in biotechnology stocks that are about to be approved that have a Prescription Drug User Fee Act date upcoming please and specifically are Orphan Drugs as i note these have a different approval pathway? From the last 60 companies with drugs ready to be approved around 50 drugs have been approved (the share price increases with it), with the other 10 not being rejected, but having to sort issues out with their manufacturing process. If anyone kindly had any thoughts on this i would be forever grateful and thankful it would mean the world to me.
Thank you to all the amazing people on this forum who have helped me ever so much with my investing journey. The people on this forum are incredible. Sending you lots of good wishes and i truly hope you continue to have a wonderful and happy life. I truly wish you all the very best with your investing. With the very best of wishes to you.